SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nord who wrote (5491)10/14/1998 10:38:00 AM
From: John Romeo  Read Replies (1) of 6136
 
I find it interesting Roche has it's own PI and can sell AGPH at the same time, aren't there conflicts of interests.Also how Roche tried to
screw AGPH on the oncology biz by dropping one and wanting to pick and
choose which cancer drug they wanted to continue with. Versus their
original agreement. AGPH showed strong backbone and told them all or none. It just seems like odd bedfellows, also with fotorvase being a
bid. PI. Would there be a clear conflict when Viracept gets bid, approval.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News